ANI Pharma (ANIP) Tops Q1 EPS by 4c

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.32, $0.04 better than the analyst estimate of $1.28. Revenue for the quarter came in at $46.5 million versus the consensus estimate of $49.93 million.

• ANI Reaffirms Guidance for the Full Year 2018

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity